Terms: = Breast cancer AND BCL2, Bcl-2, 596, ENSG00000171791 AND Prognosis
413 results:
1. Discovery of ganoderic acid A (GAA) PROTACs as MDM2 protein degraders for the treatment of breast cancer.
Li Y; Li G; Zuo C; Wang X; Han F; Jia Y; Shang H; Tian Y
Eur J Med Chem; 2024 Apr; 270():116367. PubMed ID: 38581732
[TBL] [Abstract] [Full Text] [Related]
2. Combined effects of naringin and doxorubicin on the JAK/STAT signaling pathway reduce the development and spread of breast cancer cells.
Effat H; Abosharaf HA; Radwan AM
Sci Rep; 2024 Feb; 14(1):2824. PubMed ID: 38310190
[TBL] [Abstract] [Full Text] [Related]
3. Apoptosis-driven synergistic anti-cancer efficacy of ethyl acetate extract of Memecylon sisparense Gamble leaves and doxorubicin in in-vitro and in-vivo models of triple-negative breast cancer.
Uppu JL; Challa VS; Syamprasad NP; Manepalli P; Naidu V; Syed A; Roshan S; Tazneem B; Almalki WH; Alharbi KS; Gupta G
Pathol Res Pract; 2024 Jan; 253():155032. PubMed ID: 38176306
[TBL] [Abstract] [Full Text] [Related]
4. Ten-year clinical outcome, toxicity and compliance of dose-dense sequential adjuvant administration of cyclophosphamide & epirubicin followed by docetaxel in patients with early breast cancer: A hellenic cooperative oncology group observational study (HE 10/10) with concurrent investigation of significance of tumor infiltrating lymphocytes.
Dimitrakopoulos FI; Goussia A; Koliou GA; Dadouli K; Batistatou A; Kourea HP; Bobos M; Arapantoni-Dadioti P; Tzaida O; Koletsa T; Chrisafi S; Sotiropoulou M; Papoudou-Bai A; Nicolaou I; Charchanti A; Mauri D; Aravantinos G; Binas I; Res E; Psyrri A; Pectasides D; Bafaloukos D; Koumarianou A; Bompolaki I; Rigakos G; Karanikiotis C; Koutras A; Zagouri F; Gogas H; Fountzilas G
Breast; 2024 Feb; 73():103668. PubMed ID: 38176305
[TBL] [Abstract] [Full Text] [Related]
5. Yttrium Oxide nanoparticles induce cytotoxicity, genotoxicity, apoptosis, and ferroptosis in the human triple-negative breast cancer MDA-MB-231 cells.
Emad B; WalyEldeen AA; Hassan H; Sharaky M; Abdelhamid IA; Ibrahim SA; Mohamed HR
BMC Cancer; 2023 Nov; 23(1):1151. PubMed ID: 38012585
[TBL] [Abstract] [Full Text] [Related]
6. Actinomycin D synergizes with Doxorubicin in triple-negative breast cancer by inducing P53-dependent cell apoptosis.
Yang H; Li S; Li W; Yang Y; Zhang Y; Zhang S; Hao Y; Cao W; Xu F; Wang H; Du G; Wang J
Carcinogenesis; 2024 Apr; 45(4):262-273. PubMed ID: 37997385
[TBL] [Abstract] [Full Text] [Related]
7. Immunoexpression of HER2 pathway related markers in HER2 invasive breast carcinomas treated with trastuzumab.
Franco AFDV; Malinverni ACM; Waitzberg AFL
Pathol Res Pract; 2023 Dec; 252():154917. PubMed ID: 37977031
[TBL] [Abstract] [Full Text] [Related]
8. bcl2A1 is associated with tumor-associated macrophages and unfavorable prognosis in human gliomas.
Gao L; Ye Z; Peng S; Lei P; Song P; Li Z; Zhou L; Hua Q; Cheng L; Wei H; Liu J; Cai Q
Aging (Albany NY); 2023 Oct; 15(20):11611-11638. PubMed ID: 37889551
[TBL] [Abstract] [Full Text] [Related]
9. [Mechanism of Astragali Radix-Curcumae Rhizoma in treating gastric cancer based on network pharmacology and experimental verification].
Tan XY; Tao J; Zhang Y; Gu RX
Zhongguo Zhong Yao Za Zhi; 2023 Sep; 48(18):5056-5067. PubMed ID: 37802848
[TBL] [Abstract] [Full Text] [Related]
10. Identification of a novel five ferroptosis-related gene signature as a promising prognostic model for breast cancer.
Cheng TC; Wu JH; Zhu B; Gao HY; Zheng L; Chen WX
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16779-16795. PubMed ID: 37728703
[TBL] [Abstract] [Full Text] [Related]
11. Deubiquitinase USP19 modulates apoptotic calcium release and endoplasmic reticulum stress by deubiquitinating BAG6 in triple negative breast cancer.
Zhang X; Chen X; Qian F; Zhu Y; He G; Yang J; Wu X; Zhang H; Yu X; Liu X
Clin Transl Med; 2023 Sep; 13(9):e1398. PubMed ID: 37700495
[TBL] [Abstract] [Full Text] [Related]
12. Spatial transcriptomic analysis of tumour with high and low CAIX expression in TNBC tissue samples using GeoMx™ RNA assay.
Shamis SA; Savioli F; Ammar A; Al-Badran SS; Hatthakarnkul P; Leslie H; Mallon EE; Jamieson NB; McMillan DC; Edwards J
Histol Histopathol; 2024 Feb; 39(2):177-200. PubMed ID: 37681672
[TBL] [Abstract] [Full Text] [Related]
13. BNIP3 as a potential biomarker for the identification of prognosis and diagnosis in solid tumours.
Yu Q; Fu W; Fu Y; Ye W; Yan H; Yu Z; Li R; Cai Y; Chen Y; Wang L; Wei X; Chen Y; Zhang Y; Ying H; Tang F; Dai F; Han W
Mol Cancer; 2023 Aug; 22(1):143. PubMed ID: 37649051
[TBL] [Abstract] [Full Text] [Related]
14. Optimizing treatment of brain metastases in an era of novel systemic treatments: a single center consecutive series.
van Schie P; Rijksen BLT; Bot M; Wiersma T; Merckel LG; Brandsma D; Compter A; de Witt Hamer PC; Post R; Borst GR
J Neurooncol; 2023 Jun; 163(2):345-354. PubMed ID: 37266846
[TBL] [Abstract] [Full Text] [Related]
15. Organoid models derived from patients with malignant phyllodes tumor of the breast.
Chu X; Wu M; Yang J; Fu Y; Wang X; Wang H; Xiao Y; Chen D; He J
Breast Cancer Res Treat; 2023 Jul; 200(2):193-201. PubMed ID: 37204665
[TBL] [Abstract] [Full Text] [Related]
16. Ribosome Biogenesis Regulator 1 Homolog (RRS1) Promotes Cisplatin Resistance by Regulating AEG-1 Abundance in breast cancer Cells.
Song J; Peng C; Wang R; Hua Y; Wu Q; Deng L; Cao Y; Zhang L; Hou L
Molecules; 2023 Mar; 28(7):. PubMed ID: 37049702
[TBL] [Abstract] [Full Text] [Related]
17. Hypoxia-induced autophagy in triple negative breast cancer: association with prognostic variables, patients' survival and response to neoadjuvant chemotherapy.
El-Guindy DM; Ibrahim FM; Ali DA; El-Horany HE; Sabry NM; Elkholy RA; Mansour W; Helal DS
Virchows Arch; 2023 May; 482(5):823-837. PubMed ID: 36939902
[TBL] [Abstract] [Full Text] [Related]
18. Wnt Signaling Pathway Collapse upon β-Catenin Destruction by a Novel Antimicrobial Peptide SKACP003: Unveiling the Molecular Mechanism and Genetic Activities Using breast cancer Cell Lines.
Selvarathinam K; Subramani P; Thekkumalai M; Vilwanathan R; Selvarajan R; Abia ALK
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770598
[TBL] [Abstract] [Full Text] [Related]
19. Multi-candidate immunohistochemical markers to assess radiation response and prognosis in prostate cancer: results from the CHHiP trial of radiotherapy fractionation.
Wilkins A; Gusterson B; Tovey H; Griffin C; Stuttle C; Daley F; Corbishley CM; Dearnaley D; Hall E; Somaiah N
EBioMedicine; 2023 Feb; 88():104436. PubMed ID: 36708693
[TBL] [Abstract] [Full Text] [Related]
20. BAG2 drives chemoresistance of breast cancer by exacerbating mutant p53 aggregate.
Huang X; Shi D; Zou X; Wu X; Huang S; Kong L; Yang M; Xiao Y; Chen B; Chen X; Ouyang Y; Song L; Jian Y; Lin C
Theranostics; 2023; 13(1):339-354. PubMed ID: 36593950
[No Abstract] [Full Text] [Related]
[Next]
